MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping - PubMed (original) (raw)
. 2000 Aug 4;275(31):23530-9.
doi: 10.1074/jbc.M909002199.
Affiliations
- PMID: 10918072
- DOI: 10.1074/jbc.M909002199
Free article
MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping
A J Smith et al. J Biol Chem. 2000.
Free article
Abstract
The human MDR3 gene is a member of the multidrug resistance (MDR) gene family. The MDR3 P-glycoprotein is a transmembrane protein that translocates phosphatidylcholine. The MDR1 P-glycoprotein related transports cytotoxic drugs. Its overexpression can make cells resistant to a variety of drugs. Attempts to show that MDR3 P-glycoprotein can cause MDR have been unsuccessful thus far. Here, we report an increased directional transport of several MDR1 P-glycoprotein substrates, such as digoxin, paclitaxel, and vinblastine, through polarized monolayers of MDR3-transfected cells. Transport of other good MDR1 P-glycoprotein substrates, including cyclosporin A and dexamethasone, was not detectably increased. MDR3 P-glycoprotein-dependent transport of a short-chain phosphatidylcholine analog and drugs was inhibited by several MDR reversal agents and other drugs, indicating an interaction between these compounds and MDR3 P-gp. Insect cell membranes from Sf9 cells overexpressing MDR3 showed specific MgATP binding and a vanadate-dependent, N-ethylmaleimide-sensitive nucleotide trapping activity, visualized by covalent binding with [alpha-(32)P]8-azido-ATP. Nucleotide trapping was (nearly) abolished by paclitaxel, vinblastine, and the MDR reversal agents verapamil, cyclosporin A, and PSC 833. We conclude that MDR3 P-glycoprotein can bind and transport a subset of MDR1 P-glycoprotein substrates. The rate of MDR3 P-glycoprotein-mediated transport is low for most drugs, explaining why this protein is not detectably involved in multidrug resistance. It remains possible, however, that drug binding to MDR3 P-glycoprotein could adversely affect phospholipid or toxin secretion under conditions of stress (e.g. in pregnant heterozygotes with one MDR3 null allele).
Similar articles
- MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine.
van Helvoort A, Smith AJ, Sprong H, Fritzsche I, Schinkel AH, Borst P, van Meer G. van Helvoort A, et al. Cell. 1996 Nov 1;87(3):507-17. doi: 10.1016/s0092-8674(00)81370-7. Cell. 1996. PMID: 8898203 - Transport of phosphatidylcholine in MDR3-negative epithelial cell lines via drug-induced MDR1 P-glycoprotein.
Abulrob AG, Gumbleton M. Abulrob AG, et al. Biochem Biophys Res Commun. 1999 Aug 19;262(1):121-6. doi: 10.1006/bbrc.1999.1120. Biochem Biophys Res Commun. 1999. PMID: 10448079 - Transepithelial transport of drugs by the multidrug transporter in cultured Madin-Darby canine kidney cell epithelia.
Horio M, Chin KV, Currier SJ, Goldenberg S, Williams C, Pastan I, Gottesman MM, Handler J. Horio M, et al. J Biol Chem. 1989 Sep 5;264(25):14880-4. J Biol Chem. 1989. PMID: 2570070 - ABC transporters in lipid transport.
Borst P, Zelcer N, van Helvoort A. Borst P, et al. Biochim Biophys Acta. 2000 Jun 26;1486(1):128-44. doi: 10.1016/s1388-1981(00)00053-6. Biochim Biophys Acta. 2000. PMID: 10856718 Review. - Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein.
Sikic BI, Fisher GA, Lum BL, Halsey J, Beketic-Oreskovic L, Chen G. Sikic BI, et al. Cancer Chemother Pharmacol. 1997;40 Suppl:S13-9. doi: 10.1007/s002800051055. Cancer Chemother Pharmacol. 1997. PMID: 9272128 Review.
Cited by
- Drug transporters in the human blood-placental barrier.
Vähäkangas K, Myllynen P. Vähäkangas K, et al. Br J Pharmacol. 2009 Oct;158(3):665-78. doi: 10.1111/j.1476-5381.2009.00336.x. Epub 2009 Sep 25. Br J Pharmacol. 2009. PMID: 19788499 Free PMC article. Review. - Genetic Analysis of ABCB4 Mutations and Variants Related to the Pathogenesis and Pathophysiology of Low Phospholipid-Associated Cholelithiasis.
Wang HH, Portincasa P, Liu M, Wang DQ. Wang HH, et al. Genes (Basel). 2022 Jun 11;13(6):1047. doi: 10.3390/genes13061047. Genes (Basel). 2022. PMID: 35741809 Free PMC article. Review. - Probabilistic orthology analysis of the ATP-binding cassette transporters: implications for the development of multiple drug resistance phenotype.
Fisher C, Coleman T, Plant N. Fisher C, et al. Drug Metab Dispos. 2012 Jul;40(7):1397-402. doi: 10.1124/dmd.112.045062. Epub 2012 Apr 16. Drug Metab Dispos. 2012. PMID: 22511348 Free PMC article. - Reversal of adriamycin resistance in human mammary cancer cells by small interfering RNA of MDR1 and MDR3 genes.
Xiao L, Gao R, Lu S, Ren L, Wang Z. Xiao L, et al. J Huazhong Univ Sci Technolog Med Sci. 2006;26(6):735-7. doi: 10.1007/s11596-006-0630-4. J Huazhong Univ Sci Technolog Med Sci. 2006. PMID: 17357504 - Novel insights into the organic solute transporter alpha/beta, OSTα/β: From the bench to the bedside.
Beaudoin JJ, Brouwer KLR, Malinen MM. Beaudoin JJ, et al. Pharmacol Ther. 2020 Jul;211:107542. doi: 10.1016/j.pharmthera.2020.107542. Epub 2020 Apr 2. Pharmacol Ther. 2020. PMID: 32247663 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous